Application for Arts-Based Social Prescribing

Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age15-18
SponsorSocialRx Inc

About this trial

The goal of this clinical trial is to learn if a personalized arts-based social prescribing program, Art Pharmacy, delivered through a mobile app (SocialRx App) can improve mental health and social connectedness in adolescents aged 15-18 with depression or anxiety enrolled in Medicaid managed care.

The main question it aims to answer is:

Compared to stable treatment, does participation in the Art Pharmacy program through the SocialRx App improve depression, anxiety, social connectedness, and loneliness? Researchers will compare participants receiving the Art Pharmacy program and digital companion to those receiving stable treatment (no change to existing care) to evaluate its effects on mental health and social connectedness.

Participants will:

Be randomly assigned to either the Art Pharmacy program delivered through the SocialRx App or a control group receiving stable treatment.

Complete online surveys at baseline and follow-up time points (e.g., 3, 6, 9, and 12 months).

If assigned to the intervention group, Art Pharmacy, participants will receive monthly arts and cultural activity recommendations, attend activities, and interact with a care navigator delivered through the SocialRx App.

Eligibility criteria

Qualifiers

Aged 15-18 years enrolled in Medicaid managed care

Positive screen for depression and/or anxiety (e.g., PHQ-2 or GAD-2 ≥ 3)

Currently own and easily operate a smartphone

Have a valid e-mail address checked regularly

Disqualifiers

Endorse current suicidal ideation at study screening, defined as a response ≥ 1 ("several days") on Item 9 of the PHQ-9A

Initiate a new treatment regimen or plan on initiating a new treatment regimen (i.e., medication, psychotherapy, or mind-body interventions) at the time of enrollment.

Trial design

Treatments tested in this trial

  • Art Pharmacy
  • Stable treatment

Treatment groups

230 Participants
are divided into 2 treatment groups

Locations

This trial has no locations

Sponsors and collaborators

SocialRx Inc

Lead sponsor

National Center for Complementary and Integrative Health (NCCIH)

Collaborator

Boston College

Collaborator